EZH2	B:C1333368
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	B:C1421578
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	B:C0029016
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	B:C0030521
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	B:C0008972
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	B:C0544886
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	B:C0017337
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	B:C0694884
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	B:C1332803
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	B:C0919539
and	O
others	O
)	O
in	O
parathyroid	O
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

EZH2	O
and	O
ZFX	O
oncogenes	O
in	O
malignant	O
behaviour	O
of	O
parathyroid	O
neoplasms	I:C0030521
Several	O
studies	O
reported	O
somatic	O
mutations	I:C0544886
of	O
many	O
genes	O
(	O
MEN1	O
,	O
CTNNB1	O
,	O
CDKIs	O
and	O
others	O
)	O
in	O
parathyroid	B:C0262587
adenoma	I:C0262587
,	O
although	O
with	O
different	O
prevalence	O
.	O

Recently	O
,	O
activating	O
mutations	B:C0026882
of	O
the	O
EZH2	O
and	O
ZFX	O
oncogenes	O
were	O
identified	O
in	O
benign	O
parathyroid	O
adenoma	I:C0262587
by	O
whole	O
exome	I:C3640077
sequencing	I:C3640077
.	O

Recently	O
,	O
activating	O
mutations	O
of	O
the	O
EZH2	B:C1333368
and	O
ZFX	O
oncogenes	O
were	O
identified	O
in	O
benign	O
parathyroid	O
adenoma	I:C0262587
by	O
whole	O
exome	I:C3640077
sequencing	I:C3640077
.	O

Recently	O
,	O
activating	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	B:C1421578
oncogenes	O
were	O
identified	O
in	O
benign	O
parathyroid	O
adenoma	I:C0262587
by	O
whole	O
exome	I:C3640077
sequencing	I:C3640077
.	O

Recently	O
,	O
activating	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
oncogenes	B:C0029016
were	O
identified	O
in	O
benign	O
parathyroid	O
adenoma	I:C0262587
by	O
whole	O
exome	I:C3640077
sequencing	I:C3640077
.	O

Recently	O
,	O
activating	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
oncogenes	O
were	O
identified	O
in	O
benign	O
parathyroid	B:C0262587
adenoma	I:C0262587
by	O
whole	O
exome	I:C3640077
sequencing	I:C3640077
.	O

Recently	O
,	O
activating	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
oncogenes	O
were	O
identified	O
in	O
benign	O
parathyroid	O
adenoma	I:C0262587
by	O
whole	B:C3640077
exome	I:C3640077
sequencing	I:C3640077
.	O

The	O
same	O
mutations	B:C0026882
had	O
been	O
found	O
in	O
blood	O
and	O
ovary	O
malignant	O
tumours	I:C0006826
.	O

The	O
same	O
mutations	O
had	O
been	O
found	O
in	O
blood	B:C0005767
and	O
ovary	O
malignant	O
tumours	I:C0006826
.	O

The	O
same	O
mutations	O
had	O
been	O
found	O
in	O
blood	O
and	O
ovary	B:C0029939
malignant	O
tumours	I:C0006826
.	O

The	O
same	O
mutations	O
had	O
been	O
found	O
in	O
blood	O
and	O
ovary	O
malignant	B:C0006826
tumours	I:C0006826
.	O

On	O
one	O
hand	O
,	O
this	O
result	O
raised	O
the	O
hypothesis	O
that	O
these	O
oncogenes	B:C0029016
may	O
play	O
a	O
role	O
in	O
the	O
onset	O
of	O
parathyroid	O
tumour	I:C0030521
,	O
but	O
it	O
would	O
also	O
suggest	O
they	O
may	O
be	O
involved	O
in	O
malignant	O
,	O
rather	O
benign	O
,	O
parathyroid	O
neoplasm	I:C0030521
.	O

On	O
one	O
hand	O
,	O
this	O
result	O
raised	O
the	O
hypothesis	O
that	O
these	O
oncogenes	O
may	O
play	O
a	O
role	O
in	O
the	O
onset	O
of	O
parathyroid	B:C0030521
tumour	I:C0030521
,	O
but	O
it	O
would	O
also	O
suggest	O
they	O
may	O
be	O
involved	O
in	O
malignant	O
,	O
rather	O
benign	O
,	O
parathyroid	O
neoplasm	I:C0030521
.	O

On	O
one	O
hand	O
,	O
this	O
result	O
raised	O
the	O
hypothesis	O
that	O
these	O
oncogenes	O
may	O
play	O
a	O
role	O
in	O
the	O
onset	O
of	O
parathyroid	O
tumour	I:C0030521
,	O
but	O
it	O
would	O
also	O
suggest	O
they	O
may	O
be	O
involved	O
in	O
malignant	O
,	O
rather	O
benign	O
,	O
parathyroid	B:C0030521
neoplasm	I:C0030521
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	B:C0026882
of	O
the	O
EZH2	O
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	O
cohort	O
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	B:C1333368
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	O
cohort	O
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	B:C1421578
genes	I:C1421578
in	O
an	O
Italian	O
cohort	O
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	B:C0337810
cohort	O
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	O
cohort	B:C0599755
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	O
cohort	O
of	O
23	O
sporadic	O
parathyroid	B:C0687150
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	O
.	O

Our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	O
of	O
the	O
EZH2	O
and	O
ZFX	O
genes	I:C1421578
in	O
an	O
Italian	O
cohort	O
of	O
23	O
sporadic	O
parathyroid	O
carcinomas	I:C0687150
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	B:C0001430
.	O

DNA	B:C0012854
was	O
extracted	O
from	O
paraffin	O
-	I:C1519524
embedded	I:C1519524
tissues	I:C1519524
,	O
PCR	O
amplified	O
and	O
directly	O
sequenced	O
.	O

DNA	O
was	O
extracted	B:C0185115
from	O
paraffin	O
-	I:C1519524
embedded	I:C1519524
tissues	I:C1519524
,	O
PCR	O
amplified	O
and	O
directly	O
sequenced	O
.	O

DNA	O
was	O
extracted	O
from	O
paraffin	B:C1519524
-	I:C1519524
embedded	I:C1519524
tissues	I:C1519524
,	O
PCR	O
amplified	O
and	O
directly	O
sequenced	O
.	O

DNA	O
was	O
extracted	O
from	O
paraffin	O
-	I:C1519524
embedded	I:C1519524
tissues	I:C1519524
,	O
PCR	B:C0032520
amplified	O
and	O
directly	O
sequenced	O
.	O

No	B:C0205160
mutations	O
were	O
detected	O
in	O
the	O
coding	O
sequence	I:C0015295
and	O
boundaries	O
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O

No	O
mutations	B:C0026882
were	O
detected	O
in	O
the	O
coding	O
sequence	I:C0015295
and	O
boundaries	O
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O

No	O
mutations	O
were	O
detected	B:C0442726
in	O
the	O
coding	O
sequence	I:C0015295
and	O
boundaries	O
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O

No	O
mutations	O
were	O
detected	O
in	O
the	O
coding	B:C0015295
sequence	I:C0015295
and	O
boundaries	O
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O

No	O
mutations	O
were	O
detected	O
in	O
the	O
coding	O
sequence	I:C0015295
and	O
boundaries	B:C1136191
of	O
both	O
genes	O
in	O
any	O
of	O
the	O
samples	O
.	O

No	O
mutations	O
were	O
detected	O
in	O
the	O
coding	O
sequence	I:C0015295
and	O
boundaries	O
of	O
both	O
genes	B:C0017337
in	O
any	O
of	O
the	O
samples	O
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	B:C1333368
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	B:C0678941
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	B:C0150312
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	B:C0678941
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	B:C0015295
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	B:C0442726
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	B:C0020502
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	O
process	I:C0035687
.	O

Two	O
polymorphisms	O
of	O
the	O
EZH2	O
gene	I:C1333368
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs2072407	O
variant	I:C0678941
was	O
present	O
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs78589034	O
variant	I:C0678941
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	O
16	I:C0015295
,	O
was	O
detected	O
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	O
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	B:C0035687
process	I:C0035687
.	O

EZH2	B:C1333368
and	O
ZFX	O
genes	I:C1421578
do	O
not	O
seem	O
to	O
have	O
an	O
impact	O
on	O
the	O
onset	O
of	O
most	O
parathyroid	O
tumours	I:C0030521
,	O
both	O
benign	O
and	O
malignant	O
,	O
though	O
further	O
studies	O
on	O
larger	O
cohorts	O
of	O
different	O
ethnicity	O
are	O
needed	O
.	O

EZH2	O
and	O
ZFX	B:C1421578
genes	I:C1421578
do	O
not	O
seem	O
to	O
have	O
an	O
impact	O
on	O
the	O
onset	O
of	O
most	O
parathyroid	O
tumours	I:C0030521
,	O
both	O
benign	O
and	O
malignant	O
,	O
though	O
further	O
studies	O
on	O
larger	O
cohorts	O
of	O
different	O
ethnicity	O
are	O
needed	O
.	O

EZH2	O
and	O
ZFX	O
genes	I:C1421578
do	O
not	O
seem	O
to	O
have	O
an	O
impact	O
on	O
the	O
onset	O
of	O
most	O
parathyroid	B:C0030521
tumours	I:C0030521
,	O
both	O
benign	O
and	O
malignant	O
,	O
though	O
further	O
studies	O
on	O
larger	O
cohorts	O
of	O
different	O
ethnicity	O
are	O
needed	O
.	O

EZH2	O
and	O
ZFX	O
genes	I:C1421578
do	O
not	O
seem	O
to	O
have	O
an	O
impact	O
on	O
the	O
onset	O
of	O
most	O
parathyroid	O
tumours	I:C0030521
,	O
both	O
benign	O
and	O
malignant	O
,	O
though	O
further	O
studies	O
on	O
larger	O
cohorts	B:C0599755
of	O
different	O
ethnicity	O
are	O
needed	O
.	O

